(ABEV) Ambev - Ratings and Ratios
Beer, Soft Drink, Water, Energy Drink, Juice
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.05% |
| Yield on Cost 5y | 8.39% |
| Yield CAGR 5y | 8.13% |
| Payout Consistency | 77.0% |
| Payout Ratio | 55.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.5% |
| Value at Risk 5%th | 43.0% |
| Relative Tail Risk | -1.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 18.54 |
| CAGR/Max DD | -0.01 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.486 |
| Beta | 0.377 |
| Beta Downside | 0.141 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.91% |
| Mean DD | 17.69% |
| Median DD | 17.39% |
Description: ABEV Ambev September 29, 2025
Ambev S.A., through its subsidiaries, produces, distributes, and sells a broad portfolio of alcoholic and non-alcoholic beverages-including beer, draft beer, carbonated soft drinks, malt-based drinks, bottled water, energy drinks, and ready-to-drink teas-across Brazil, Central America, the Caribbean, Latin America South, and Canada.
The company markets its products under flagship owned brands such as Brahma, Antarctica, Quilmes, and Presidente, and also carries licensed international labels including Budweiser, Corona, Stella Artois, and Red Bull, reaching consumers via both a direct-distribution network and a network of third-party distributors.
Founded in 1885 and headquartered in São Paulo, Brazil, Ambev operates as a subsidiary of Interbrew International B.V., the European arm of Anheuser-Busch InBev, and is listed on the NYSE under the ticker ABEV.
Key recent metrics: 2023 net revenue reached US$ 15.9 billion, reflecting a 7 % year-over-year increase driven by volume growth in Brazil’s premium-segment beers; EBITDA margin held steady at 23 %; and the company’s market share in Brazil’s beer market remains above 60 %, giving it pricing power in a region where consumer spending is sensitive to real-exchange-rate fluctuations and commodity input costs (e.g., barley, aluminum). Additionally, Ambev’s aggressive rollout of low- and no-sugar soft-drink variants aligns with the broader Latin-American health-trend, which is expected to lift non-beer category growth by 3-4 % annually.
For a deeper, data-driven assessment of Ambev’s valuation dynamics and scenario analysis, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (16.04b TTM) > 0 and > 6% of Revenue (6% = 5.43b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 0.63pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.93% (prev 8.49%; Δ -2.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 25.09b > Net Income 16.04b (YES >=105%, WARN >=100%) |
| Net Debt (-15.41b) to EBITDA (28.74b) ratio: -0.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.67b) change vs 12m ago -0.91% (target <= -2.0% for YES) |
| Gross Margin 51.77% (prev 50.98%; Δ 0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 62.82% (prev 55.95%; Δ 6.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.60 (EBITDA TTM 28.74b / Interest Expense TTM 2.65b) >= 6 (WARN >= 3) |
Altman Z'' 5.26
| (A) 0.04 = (Total Current Assets 41.94b - Total Current Liabilities 36.58b) / Total Assets 140.75b |
| (B) 0.05 = Retained Earnings (Balance) 7.43b / Total Assets 140.75b |
| (C) 0.16 = EBIT TTM 22.78b / Avg Total Assets 144.02b |
| (D) 3.59 = Book Value of Equity 172.61b / Total Liabilities 48.03b |
| Total Rating: 5.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 87.23
| 1. Piotroski 8.0pt |
| 2. FCF Yield 10.34% |
| 3. FCF Margin 22.78% |
| 4. Debt/Equity 0.03 |
| 5. Debt/Ebitda -0.54 |
| 6. ROIC - WACC (= 14.47)% |
| 7. RoE 16.99% |
| 8. Rev. Trend 36.96% |
| 9. EPS Trend 36.94% |
What is the price of ABEV shares?
Over the past week, the price has changed by -0.79%, over one month by +13.06%, over three months by +14.09% and over the past year by +25.68%.
Is ABEV a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ABEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.8 | 13.1% |
| Analysts Target Price | 2.8 | 13.1% |
| ValueRay Target Price | 3 | 17.9% |
ABEV Fundamental Data Overview November 26, 2025
P/E Trailing = 13.2632
P/E Forward = 12.7877
P/S = 0.4438
P/B = 2.2403
P/EG = 1.3317
Beta = 0.272
Revenue TTM = 90.47b BRL
EBIT TTM = 22.78b BRL
EBITDA TTM = 28.74b BRL
Long Term Debt = 264.1m BRL (from longTermDebt, last quarter)
Short Term Debt = 1.05b BRL (from shortTermDebt, last quarter)
Debt = 2.90b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = -15.41b BRL (from netDebt column, last quarter)
Enterprise Value = 199.39b BRL (216.33b + Debt 2.90b - CCE 19.84b)
Interest Coverage Ratio = 8.60 (Ebit TTM 22.78b / Interest Expense TTM 2.65b)
FCF Yield = 10.34% (FCF TTM 20.61b / Enterprise Value 199.39b)
FCF Margin = 22.78% (FCF TTM 20.61b / Revenue TTM 90.47b)
Net Margin = 17.73% (Net Income TTM 16.04b / Revenue TTM 90.47b)
Gross Margin = 51.77% ((Revenue TTM 90.47b - Cost of Revenue TTM 43.64b) / Revenue TTM)
Gross Margin QoQ = 51.46% (prev 50.00%)
Tobins Q-Ratio = 1.42 (Enterprise Value 199.39b / Total Assets 140.75b)
Interest Expense / Debt = 24.85% (Interest Expense 719.7m / Debt 2.90b)
Taxrate = 6.72% (350.2m / 5.21b)
NOPAT = 21.25b (EBIT 22.78b * (1 - 6.72%))
Current Ratio = 1.15 (Total Current Assets 41.94b / Total Current Liabilities 36.58b)
Debt / Equity = 0.03 (Debt 2.90b / totalStockholderEquity, last quarter 92.03b)
Debt / EBITDA = -0.54 (Net Debt -15.41b / EBITDA 28.74b)
Debt / FCF = -0.75 (Net Debt -15.41b / FCF TTM 20.61b)
Total Stockholder Equity = 94.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.39% (Net Income 16.04b / Total Assets 140.75b)
RoE = 16.99% (Net Income TTM 16.04b / Total Stockholder Equity 94.42b)
RoCE = 24.06% (EBIT 22.78b / Capital Employed (Equity 94.42b + L.T.Debt 264.1m))
RoIC = 22.08% (NOPAT 21.25b / Invested Capital 96.24b)
WACC = 7.61% (E(216.33b)/V(219.23b) * Re(7.40%) + D(2.90b)/V(219.23b) * Rd(24.85%) * (1-Tc(0.07)))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 79.64% ; FCFE base≈20.62b ; Y1≈22.73b ; Y5≈29.30b
Fair Price DCF = 32.67 (DCF Value 509.48b / Shares Outstanding 15.59b; 5y FCF grow 11.74% → 3.0% )
EPS Correlation: 36.94 | EPS CAGR: 2.95% | SUE: 0.10 | # QB: 0
Revenue Correlation: 36.96 | Revenue CAGR: -1.44% | SUE: -0.03 | # QB: 0
Additional Sources for ABEV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle